Biocidal Products Committee: Applicants responsible for making sure their dossiers are complete

Safer Chemicals Podcast

ECHA’s Biocidal Products Committee met during the last week of May 2024 and adopted altogether 18 opinions.

Join Päivi Jokiniemi and Joost van Galen, the Chair of the Biocidal Products Committee, in this episode of Safer Chemicals Podcast. They discuss, for example, what happens when the assessment of endocrine disrupting properties is lacking from applications. Joost also comes back to the topic of data gaps and missing information, and reminds companies of their responsibility of making sure that their applications are complete and meet the data requirements under the Biocidal Products Regulation.

The Committee’s task is to prepare scientific opinions for the European Commission on biocidal active substances and on EU-wide authorisations of biocidal products. The Commission takes the final decisions based on these opinions.

Useful links

• More episodes on the Biocidal Products Committee meetings

• Give us feedback

More

• ECHA raises concern over missing data in biocides applications - ECHA news, 5 June 2024

• Agenda of the May 2024 BPC meeting [PDF] [EN]

• Understanding the Biocidal Products Regulation

• Biocidal Products Regulation (528/2012)

• Guidance on biocides legislation

• Biocidal Products Committee (contains also working procedures)

**************

• Subscribe to our YouTube channel

• Subscribe to our Safer Chemicals Podcast

• Subscribe to our news

Follow us on:

• Twitter

• Facebook

• LinkedIn

Visit our website

Disclaimer: Views expressed by interviewees do not necessarily represent the official position of the European Chemicals Agency. All content is up to date at the time of publication.

Hosted by Ausha. See ausha.co/privacy-policy for more information.

Chương

1. Introduction of the topics and guest of the podcast (00:01:09)

2. First spontaneous reflections after the meeting? (00:01:33)

3. Main themes of the meeting (00:02:08)

4. Focusing on missing information (00:05:31)

5. What resources are available for companies when they prepare their applications? (00:08:23)

6. Assessment of endocrine disrupting properties (00:10:53)

7. Reasons behind of the increasing number of applications that are missing the ED assessment (00:11:48)

8. Applicants are responsible for submitting complete dossiers (00:14:03)

9. Submit information in time (00:16:33)

10. Assessment of misuse (00:18:42)

11. Conclusions and details on useful links (00:19:43)